Nov
Newswise — NEW YORK – November 20, 2023 – The Cardiovascular Research Foundation (CRF), in conjunction with the Transcatheter Cardiovascular Therapeutics (TCT) 2023 conference, CRF’s annual scientific symposium, announced today the launch of the CRF Scientific Excellence Top 10 (SET-10), a new global annual ranking recognizing academic contributions to interventional cardiovascular medicine. The SET-10 initiative, […]
Infection
Molecular occurrence and genetic diversity of Ehrlichia canis in naturally infected dogs from Thailand
Nov
Abstract Canine monocytic ehrlichiosis is cause by Ehrlichia canis resulting in hematologic disorders and severe clinical signs. The aim of this study was to scrutinize the molecular detection and genetic diversity of E. canis based on the trp36 gene in dogs from Thailand’s northern and central regions. A total of 120 dogs blood samples were […]
Infection
Hepatocyte integrity depends on c-Jun-controlled proliferation in Schistosoma mansoni infected mice
Nov
Abstract Schistosomiasis is a parasitic disease affecting more than 250 million people worldwide. The transcription factor c-Jun, which is induced in S. mansoni infection-associated liver disease, can promote hepatocyte survival but can also trigger hepatocellular carcinogenesis. We aimed to analyze the hepatic role of c-Jun following S. mansoni infection. We adopted a hepatocyte-specific c-Jun knockout mouse model […]
Cardiovascular
Effect of educational intervention on risk factors of cardiovascular diseases among school teachers: a quasi-experimental study in a suburb of Kolkata, West Bengal, India
Nov
Participants This multicentric quasi-experimental study took place from August 2016 to May 2017 among teachers in four schools in Baruipur, a Kolkata suburb, West Bengal, India. We used simple random sampling (SRS) with replacement to select four clusters out of 18 in the Baruipur block, each containing an average of 18.5 ~ 19 schools. From each cluster, […]
Nov
Bayer announced that the phase III OCEANIC-AF study of the oral factor XIa inhibitor asundexian was stopped early due to inferior efficacy compared with apixaban (Eliquis) for patients with atrial fibrillation (Afib). The CDC reported that the age-adjusted prevalence of hypertension climbed to 44.2% in Los Angeles County and 47.3% across the U.S. from 2015 […]
Infection
Risk of SARS-CoV-2 infection and hospitalization in individuals with natural, vaccine-induced and hybrid immunity: a retrospective population-based cohort study from Estonia
Nov
Abstract A large proportion of the world’s population has some form of immunity against SARS-CoV-2, through either infection (‘natural’), vaccination or both (‘hybrid’). This retrospective cohort study used data on SARS-CoV-2, vaccination, and hospitalization from national health system from February 2020 to June 2022 and Cox regression modelling to compare those with natural immunity to […]
Nov
Heart disease is a leading cause of death in the United States. The Centers for Disease Control and Prevention cite one American dies every 33 seconds because of cardiovascular disease.1 Due to the staggering numbers, heart dysfunction is a well-researched subject. Every finding brings new knowledge to the surface — and one recently led to […]